# $crvs

Corvus Pharmaceuticals (CRVS) sees significant social media buzz driven by positive clinical data for its ITK inhibitor, soquelitinib, and analyst upgrades, though valuation concerns and short-seller reports remain a point of contention.

### About $crvs
Corvus Pharmaceuticals is a biotechnology company focused on developing novel therapeutics.  

### Insights
- $crvs mentions hit [---] which is 307% higher than it's daily average.
- $crvs engagements hit 69.3K which is 227% higher than it's daily average.
- $crvs creators hit [---] which is 233% higher than it's daily average.
- $crvs engagements is up 1024.07% from the previous week.
- $crvs posts created is up 600% from the previous week.

### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +1,024%  
[--] Month: [---------] +227%  
[--] Months: [---------] +105%  
[--] Year: [---------] +51%  
1-Year High: [-------] on 2026-01-20  
1-Year Low: [-----] on 2025-03-16  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [------]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
1-Year High: [---] on 2026-01-29  
1-Year Low: [--] on 2025-03-16  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning $crvs in the last [--] hours which is up 9.90% from [---] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2026-01-21  
1-Year Low: [--] on 2025-02-13  

The most influential creators that mention $crvs in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [------]      |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]    | [-----]       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]    | [-----]       |
| [@Tradingfast44](/creator/twitter/Tradingfast44)     | [--]    | [---]       | [--]    | [-----]       |
| [@Pharmdca](/creator/twitter/Pharmdca)               | [--]    | [-------]   | [--]     | [-----]       |
| [@zethedeuce](/creator/twitter/zethedeuce)           | [--]    | [---]       | [--]     | [---]         |
| [@Sam_capitall](/creator/twitter/Sam_capitall)       | [--]    | [---]       | [--]    | [---]         |
| [@Khalled_Stock](/creator/twitter/Khalled_Stock)     | [--]    | [---]       | [--]     | [---]         |
| [@tradingsssss](/creator/twitter/tradingsssss)       | [--]    | [-----]     | [--]     | [---]         |
| [@byebyegoodguy](/creator/twitter/byebyegoodguy)     | [--]   | [---]       | [--]     | [---]         |

[View More](/list/creators/$crvs/100)
  
  
### Sentiment: 70%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/sentiment.tsv)  
Current Value: 70%  
Daily Average: 92%  
[--] Week: 72% +3%  
[--] Month: 67% -29%  
[--] Months: 67% -28%  
[--] Year: 67% -33%  
1-Year High: 100% on 2025-02-13  
1-Year Low: 49% on 2025-10-26  

Most Supportive Themes:
- Positive Clinical Data and Analyst Upgrades: (40%) Multiple posts highlight positive clinical trial data for soquelitinib, particularly in atopic dermatitis, and recent analyst upgrades, such as Mizuho raising the price target to $30.
- Novel Mechanism of Action (ITK Inhibition): (30%) There's significant discussion around Corvus's novel ITK inhibitor mechanism, which aims to reset the immune system by modulating T-cell phenotypes, differentiating it from existing therapies.
- Potential for Broader Applications and Long-Term Benefit: (20%) Posts suggest the ITK inhibition mechanism could have broader applications beyond atopic dermatitis and may lead to long-lasting immune memory or disease remission, potentially reducing the need for continuous treatment.
  
Most Critical Themes:
- Valuation Concerns and Short Seller Reports: (70%) Some posts raise concerns about the company's high valuation relative to its current stage (early Phase 2) and reference short seller reports questioning the data and commercial viability.
- Comparison to Competitors and Market Pricing: (30%) Discussions compare Corvus's drug to competitors like Dupilumab and JAK inhibitors, with some arguing that the market is pricing in certainty for a blockbuster drug that may not materialize.
  

### Top $crvs Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"this one certainly didnt age well. $crvs +150%🤔 This can't be good right Especially combined with the fact that $CRVS is the 3rd most picked Bio Squid Games. $CRVS $NKTR $KYMR This can't be good right Especially combined with the fact that $CRVS is the 3rd most picked Bio Squid Games. $CRVS $NKTR $KYMR"  
[X Link](https://x.com/financebully/status/2022021525801705526) [@financebully](/creator/x/financebully) 2026-02-12T18:54Z [----] followers, [----] engagements


"#BIOTECHS ORAL MEDS =game changers for patients $NVO $BBIO $CRVS $VKTX $PTGX $BBIO Infigratinib's Phase [--] in ACH early 2026- KOL call this past summer by Josh $BBIO a could take 50% share within first year of market - I have not forgotten those spoken words ORAL MEDS - game changers for patients https://t.co/lY4q2mmzjy $BBIO Infigratinib's Phase [--] in ACH early 2026- KOL call this past summer by Josh $BBIO a could take 50% share within first year of market - I have not forgotten those spoken words ORAL MEDS - game changers for patients https://t.co/lY4q2mmzjy"  
[X Link](https://x.com/semodough/status/2022011238981808315) [@semodough](/creator/x/semodough) 2026-02-12T18:13Z 42.4K followers, 23.1K engagements


"$CRVS          $IVF $RAPT $ATON $SGN $NTCL $CCHH $POLA $CDT $TOVX $NUWE $UMC $MKDW $EVTV $BTTC $DXST $IVP $KEP $HCTI $NUAI $ATOS $CEPT https://x.com/messages/composerecipient_id=1817432147277316096 https://x.com/messages/composerecipient_id=1817432147277316096"  
[X Link](https://x.com/Tradingfast44/status/2022008388994117711) [@Tradingfast44](/creator/x/Tradingfast44) 2026-02-12T18:02Z [---] followers, [---] engagements


"📊  📩 $CRVS $ABVX $CRML $HMY $CABA $HL $LFWD $TLYS $ENLT $CGAU $SVM $IFBD $PALI $GFI $HYMC $AG $IAG $PAAS $SHPH $EXK $USAS https://twitter.com/messages/composerecipient_id=1817432147277316096 https://twitter.com/messages/composerecipient_id=1817432147277316096"  
[X Link](https://x.com/Tradingfast44/status/2022007780329370082) [@Tradingfast44](/creator/x/Tradingfast44) 2026-02-12T17:59Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing